Internet for Pharmaceutical and Biotech Communities
| Newsletter | Post Jobs | Advertising |
 
 

 

  

Pharm/Biotech Resources

Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

Pharm Stocks

FDA Links

FDA Warning Letters

FDA Doc/cGMP

Pharm/Biotech Events

Consultants

Advertiser Info

Newsletter Subscription

Web Links

Suggestions

Site Map
 
 
   


Patent Classification

Treatment, Genetic/Inherited Related Disorders

  1. Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
     
  2. Methods for detection of genetic disorders 
     
  3. Gene repair involving in vivo excision of targeting DNA
     
  4. Method for producing proteins suitable for treating lysosomal storage disorders
     
  5. Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
     
  6. Genetic suppression and replacement
     
  7. DNA encoding a DNA repair protein
     
  8. Treatment of glycogen storage disease type II

Treatment, Gigantism/Acromegaly

  1. DNA encoding growth hormone antagonists
     
  2. Mutant human growth hormones and their uses

Treatment, Glaucoma/Ocular Hypertension

  1. Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
     
  2. Methods for diagnosing glaucoma and discovering anti-glaucoma drugs
     
  3. Method for treating glaucoma
     
  4. Use of AP-1 activators to treat glaucoma and ocular hypertension
     
  5. Method for treating elevated intraocular pressure, including glaucoma
     
  6. Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
     
  7. Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
     
  8. Treatment of ocular hypertension and glaucoma
     
  9. Methods for treating glaucoma
     
  10. Glaucoma treatment
     
  11. Method of regulating pressure with an intraocular implant
     
  12. Use of PARP inhibitors in the treatment of glaucoma
     
  13. Drug delivery system for antiglaucomatous medication

  14. Drug of improving optic nerve head circulation disorder

  15. Upregulation of endogenous prostaglandins to lower intraocular pressure

  16. Composition and method for treating glaucoma

  17. Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma

Treatment, Glycolipid Storage Diseases/Gaucher's Disease

  1. Combination drug therapy for glycolipid storage diseases

Treatment, Gonorrhoea

  1. Method of inhibiting formation of Neisseria gonorrhea and Neisseria meningiditis
     
  2. Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria

Treatment, Gout

  1. Diagnosing an animal for pyrophosphate gout, osteoporosis, or osteoarthritis by assaying intracellular pyrophosphate content in peripheral blood cells

Treatment, Graft, Bone/Tissue/Skin

  1. Methods for enhancing graft survival by modulating heme oxygenase activity
     
  2. Matrix protein compositions for grafting
     
  3. Method and composition for skin grafts
     
  4. Targeting pharmaceutical agents to injured tissues
     
  5. Epidermal melanocyte culture formulations
     
  6. Calcium phosphate bone graft material, process for making same and osteoimplant fabricated from same
     
  7. Biomaterial derived from vertebrate liver tissue

Treatment, Growth Hormone Related Disorders

  1. Cysteine variants of erythropoietin
     
  2. Site-specific preparation of polyethylene glycol-GRF conjugates
     
  3. Modified growth hormone
     
    4.
  4. Prevention of hyperinsulinemia in subjects undergoing growth hormone (GH) treatment
     
  5. Non-aqueous injectable formulations for extended release of somatotropin
     
  6. Site-specific preparation of polyethylene glycol-grf conjugates

Treatment, Gynecological Related Disorders

  1. Method to produce a tampon that inhibits exoprotein production from gram positive bacteria
     
  2. Pharmaceutical preparation for the treatment of gynecological diseases
     
  3. Nasal spray steroid formulation and method
     
  4. Methods and compositions for treating benign gynecological disorders

Treatment, Haemophilus Influenzae Related Disorders

  1. Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide
     
  2. Multi-component vaccine comprising at least three antigens to protect against disease cased by Haemophilus influenzae
     
  3. Bioactive rice flour extract useful for treatment of haemophilus influenzae infections
     
  4. OMP26 antigen from Haemophilus influenzae

Treatment, Hair Growth/Alopecia/Hair Removal

  1. Compositions and methods for dual therapies of hair graying and balding in follicular delivery systems
     
  2. Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment
     
  3. Herbal hair growth inhibitor and depilation accelerator
     
  4. Identification and use of inhibitors of hair growth
     
  5. Methods of promoting hair growth
     
  6. Compositions and methods relating to prevention of chemotherapy-induced alopecia
     
  7. Method for stimulating hair follicle cell proliferation
     
  8. Oligopeptides for promoting hair growth
     
  9. Inhibitors of proteasomal activity for stimulating hair growth
     
  10. Hair follicle growth factor proteins
     
  11. Compositions and method for promoting the growth of human hair
     
  12. Method of inhibiting hair growth
     
  13. Inhibitors of proteasomal activity for stimulating hair growth
     
  14. Methods of modulating hair growth
     
  15. Methods of inducing hair growth and coloration
     
  16. Treatment of alopecia
     
  17. Method of treating hair loss
     
  18. Methods for treating and preventing alopecia
     
  19. Compositions containing minoxidil and saw palmetto for treating baldness
     
  20. Method to promote, stimulate and/or delay hair loss by a brady kinin antagonist
     
  21. Modulating body/cranial hair growth
     
  22. Methods for altering hair growth and hair pigmentation by apoptosis in the follicular papillae and compositions therefor

  23. Methods for treating alopecia

  24. Hair growth stimulant

  25. Topical preparation for the treatment of hair loss

  26. Composition and method for topical treatment of androgenic alopecia
     
  27. Preparation for improving hair growth, the skin structure and/or nail regeneration
     
  28. Minoxidil compositions for external use
     
  29. Sustained release hair growth composition
     
  30. Agents and compositions thereof for the hair treatment
     
  31. Dietary supplement containing herbal extracts which promotes healthy hair growth on the scalp
     
  32. Pharmaceutical composition comprising starch, a compound comprising boron, a compound comprising zinc, and water, and a method of using same to encourage hair growth
     
  33. Hair growers having actions of promoting proliferation of hair papilla cells

Treatment, Hangover

  1. Hangover relief composition
     
  2. Hangover treatment

Treatment, Headache

  1. Delivery of compounds for the treatment of headache through an inhalation route
     
  2. Composition of medicine for treating headache disease and process of preparation and uses thereof
     
  3. Methods for treating sinus headache
     
  4. Methods for treating tension headache
     
  5. Method for treating headache
     
  6. Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
     
  7. Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases
     
  8. Method and composition for treatment of headache using magnesium

Treatment, Hearing Loss/Meniere Disease

  1. Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
     
  2. Transductin-1 and transductin-2 and applications to hereditary deafness
     
  3. Compositions to detect lesions associated with hearing loss in the cochlear gene, COCH5B2
     
  4. Treatment of inner ear hair cells
     
  5. Methods for treating hearing loss
     
  6. Methods of diagnosis and treatment of meniere disease
     
  7. Treatment of inner ear hair cells
     
  8. Cytokine antagonists for the treatment of sensorineural hearing loss

Treatment, Helicobacter Infection

  1. Glycoprotein having inhibitory activity against helicobacter pylori colonization
     
  2. Immunodulatory complex and use thereof in helicobacter diseases
     
  3. Treatment and prevention of helicobacter infection
     
  4. Adherence gene from Helicobacter pylori and polypeptide coded thereby
     
  5. Treatment and prevention of helicobacter infection

Treatment, Hematopoietic Cells, Restoring/Neutropenia

  1. Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cells
     
  2. Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production

Treatment, Hemorrhoid/Anorectal Related Disorders

  1. Anti-hemorrhoid composition and process for its manufacture
     
  2. Hemorrhoid therapeutic treatment
     
  3. Composition and method for the treatment of anorectal disorders
     
  4. Composition of matter and method for the relief of hemorrhoidal conditions
     
  5. Integrated comprehensive hemorrhoid treatment compositions and regimen

Treatment, Hepatic/Liver, Disorders/Hepatitis

  1. Nucleic acid injected into hepatic vein lumen
     
  2. Compositions and methods for detection of hepatitis A virus nucleic acid
     
  3. Systems for expressing toxic proteins, vectors and method of producing toxic proteins
     
  4. Mammalian immortalized liver cell
     
  5. Compositions and methods for generation of infectious hepatitis C virus in immortalized human hepatocytes
     
  6. Method of treatment of viral hepatitis C with interferon alpha 5
     
  7. Chimeric GB virus B (GBV-B)
     
  8. Methods of reducing serum alanine transferase levels in a subject with hepatitis
     
  9. Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
     
  10. Yeast-based therapeutic for chronic hepatitis C infection
     
  11. Hepatitis C virus non-structural NS3/4A fusion gene
     
  12. Replication of hepatitis C virus in non-hepatic epithelial and mouse hepatic cells
     
  13. Multivalent vaccine composition having increased stability of capsular polysaccharide
     
  14. Detection and treatment of cancers of the liver
     
  15. Hepatitis C Virus NS5B polymerase inhibitor binding pocket
     
  16. Diagnosis and treatment of hepatic disorders
     
  17. Stabilized HBc chimer particles as immunogens for chronic hepatitis
     
  18. Treatment of hepatitis C in the Asian population with subcutaneous interferon-beta
     
  19. Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor
     
  20. Method for treating a viral infection related or a chemical toxin related hepatic injury with deltorphin D
     
  21. Drugs for liver diseases
     
  22. Agents for treatment of HCV and methods of use
     
  23. Polynucleotides encoding a multiple epitope fusion antigen for use in an HCV antigen/antibody combination assay
     
  24. Constructs and methods for expression of recombinant HCV envelope proteins
     
  25. Regulatory elements for delivery to the liver
     
  26. GB virus C and methods of treating viral infections
     
  27. Hepatocytes for therapy and drug screening made from embryonic stem cells
     
  28. Complex of hepatitis B virus-specific antigenic peptides associated with heat shock proteins and the application thereof
     
  29. Human monoclonal antibody against hepatitis C virus E2 glycoprotein
     
  30. Methods for the treatment of hepatic disorders
     
  31. Hepatitis C virus non-structural NS3/4A fusion gene
     
  32. Method for therapy of liver tumors
     
  33. Alanine- and glycine-containing therapeutic agent for hepatitis
     
  34. Treatment of hepatitis C with thymosin and peptide combination therapy
     
  35. Hepatitis B virus surface antigen mutant and methods of detection thereof
     
  36. In vivo induction for enhanced function of isolated hepatocytes
     
  37. Nucleic acid injected into hapatic vein lumen and delivered to primate liver
     
  38. Hepatitis B virus surface antigen mutant and methods of detection thereof
     
  39. Methods for treating viral infection using IL-28 and IL-29
     
  40. Hepatic disorder suppressant
     
  41. Liver tumor marker sequences
     
  42. Humanized antibody specific for surface antigen pre-S1 of HBV and preparation method thereof
     
  43. Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the same
     
  44. Remedies for hepatitis C
     
  45. Method and compositions for treating hepatocellular cancer
     
  46. HCV core protein binding agents for treatment of hepatitis C virus infection
     
  47. Cloned genome of infectious hepatitis C virus of genotype 2A and uses thereof
     
  48. Hepatic disorder suppressant
     
  49. Genetic immunization with nonstructural proteins of hepatitis C virus
     
  50. Treatment of hepatic fibrosis with imatinib mesylate
     
  51. Vaccine-induced hepatitis B viral strain and uses thereof
     
  52. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
     
  53. Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
     
  54. Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis
     
  55. Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs
     
  56. Utilization of interferon alpha 5 in the treatment of viral hepatopathies
     
  57. Propagation of human hepatocytes in non-human animals
     
  58. Hepatitis A vaccines
     
  59. Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection
     
  60. Mosaic protein and restriction endonuclease assisted ligation method for making the same
     
  61. Self-replicating RNA molecule from hepatitis C virus
     
  62. Anti hepatitis C virus antibody and uses thereof
     
  63. Synergistic composition of trans-tetracos-15-enoic acid and Apocynin and method of treatment for hepatotoxicity
     
  64. 3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof
     
  65. Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
     
  66. Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis C
     
  67. Hepatitis B virus treatment
     
  68. Methods and compositions for treating hepatitis B
     
  69. Combined hepatitis B treatment
     
  70. Hepatitis vaccines containing 3-O-deacylated monophoshoryl lipid A
     
  71. Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
     
  72. Freeze-dried hepatitis A attenuated live vaccine and its stabilizer
     
  73. Hepatitis-C virus type 4, 5, and 6
     
  74. Liver stem cell
     
  75. Amino acid-containing albumin preparation
     
  76. Vaccines containing ribavirin and methods of use thereof
     
  77. Methods for the simultaneous detection of HCV antigens and HCV antibodies
     
  78. Monoclonal antibodies to the human LDL receptor, their production and use
     
  79. Method of treating anemia caused by ribavirin treatment of hepatitis C using erythropoietin alpha
     
  80. Production of replicative hepatitis C virus
     
  81. Ribavirin-pegylated interferon alfa induction HCV combination therapy
     
  82. Method of production of purified hepatitis a virus particles and vaccine preparation
     
  83. Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease
     
  84. Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
     
  85. Long-term three dimensional tissue culture system
     
  86. Treatment of liver disease and injury with CXC chemokines
     
  87. Self-replicating RNA molecule from hepatitis C virus
     
  88. In vivo induction for enhanced function of isolated hepatocytes
     
  89. Treatment of hepatitis C virus infections with interleukin-10
     
  90. Hepatitus A virus vaccines
     
  91. Carrier for gene detection and its use for detecting validity of interferon therapy
     
  92. Mice comprising engrafted functional human hepatocytes
     
  93. Synthetic hepatitis C genes
     
  94. Composition and method for diagnosing auto-immune hepatitis
     
  95. Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
     
  96. Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
     
  97. Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis
     
  98. Pharmaceutical formulation useful for the treatment of hepatitis B, hepatitis C and other viral infections of the liver and a process for its preparation
     
  99. Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
     
  100. Composition for the treatment of hepatitis including HCV
     
  101. Complex of lipo-viro-particles, method of preparation and applications
     
  102. Hepatitis B virus inhibitors
     
  103. Vaccine composition for preventing or treating hepatitis C
     
  104. Polyethylene glycol modified interferon therapy
     
  105. Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
     
  106. Antisense ogligonucleotides against Hepatitis B viral replication
     
  107. Combination therapy method for treating chronic hepatitis B
     
  108. Hepatitis B vaccine
     
  109. Method for inducing hepatic fibrosis by repeated administration of allylalcohol
     
  110. Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection
     
  111. Liver fat accumulation inhibitory composition, food additive for liver fat accumulation, inhibition, and method of inhibiting liver fat accumulation
     
  112. Continuous low-dose cytokine infusion therapy
     
  113. Combined hepatitis and herpesvirus antigen compositions
     
  114. Production of replicative hepatitis C virus
     
  115. Method for producing non-infectious recombinant picornavirus particles
     
  116. Hepatitis A virus vaccines
     
  117. Synthesis and purification of hepatitis C virus-like particles

  118. Liposomes comprising peptide antigens derived from X protein of hepatitis B virus

  119. Hepatitis C E1 and E2 truncated polypeptides and methods of obtaining the same
     
  120. Polypeptides displaying HBV antigenicity or hbv antigen specificity
     
  121. Liver cell clones for use in extracorporeal liver-assist device
     
  122. Compositions and methods for treating hepatitis-C
     
  123. Hepatitis C virus asialoglycoproteins
     
  124. Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
     
  125. Method of treating depressed reticuloendothelial system function
     
  126. L-ergothioneine, Milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage

Treatment, Herpes/Epstein-Barr Related Illnesses

  1. Protective antigen of epstein barr virus
     
  2. Synthetic peptide, inhibitor to DNA viruses
     
  3. Unit dosage forms for the treatment of herpes simplex
     
  4. Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
     
    5.
  5. Diagnostics and therapy of epstein-barr virus in autoimmune disorders
     
  6. Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
     
  7. Ligand for herpes simplex virus entry mediator and methods of use
     
  8. Aluminum-zirconium compound-based treatment for herpes simplex virus lesions
     
  9. Tape material for transcutaneous absorption
     
  10. Immunization against herpes simplex virus
     
  11. Topical transdermal treatments
     
  12. Herpes virus complementing cell line
     
  13. Method and composition for treating viral outbreaks
     
  14. Anti-HSV agent for inhibiting replication of HSV-1 and HSV-2 and method of producing a substance having anti-HSV activity
     
  15. Peptides for inhibition of herpes simplex virus entry
     
  16. Methods of treating human females susceptible to HSV infection
     
  17. Compositions and methods for the treatment of viral disorders
     
  18. Spliced gene of KSHV / HHV8, its promoter and monoclonal antibodies specific for LANA2
     
  19. Cellular proteins which mediate herpesvirus entry
     
  20. Herpes simplex virus VP22 vaccines and methods of use
     
  21. Soluble herpesvirus glycoprotein complex vaccine
     
  22. Bupropion to treat herpes viral diseases
     
  23. Anti viral composition
     
  24. Method for diagnosis of Epstein-Barr virus associated disease
     
  25. Sun-protection formulations active against herpes simplex viruses
     
  26. Unit dosage forms for the treatment of herpes simplex
     
  27. Combined hepatitis and herpesvirus antigen compositions
     
  28. Human cytomegalovirus DNA constructs and uses therefor
     
  29. Method for treating nerve injury pain associated with shingles

  30. Herpes simplex virus ORF P is a repressor of viral protein synthesis

  31. Peptides and nucleic acid sequences related to the Epstein Barr virus

  32. Antimicrobial treatment for herpes simplex virus and other infectious diseases

  33. Method and topical treatment composition for herpesvirus hominis

  34. Anti-herpesviral agent
     
  35. Oligonucleotide therapies for modulating the effects of herpesviruses
     
  36. Treatment of herpes infection with composition containing quaternary ammonium compound and an anti-viral agent
     
  37. Unit dosage forms for the treatment of herpes simplex

Treatment, Homeostasis

  1. Composition comprising theanine

Treatment, Hormonal Replacement/Related Disorders

  1. Treatment of conditions relating to hormone deficiencies by administration of progestins
     
  2. Estrogen receptor genes
     
  3. 17.beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
     
  4. Melanin-concentrating hormone analogs
     
  5. Pharmaceutical compositions for nasal delivery of oestradiol and norethisterone
     
  6. Topical oestroprogestational compositions with a systemic effect
     
  7. Testosterone derivative
     
  8. Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same
     
  9. Bio-identical hormones and method of use
     
  10. Nasal spray formulation and method
     
  11. Method for modulating steroidogenic activity
     
  12. Laminates containing an active substance transdermal system
     
  13. Dosage forms and methods for oral delivery of progesterone
     
  14. Hormonal composition consisting of an oestrogen compound and of a progestational compound
     
  15. Polymeric delivery formulations of leuprolide with improved efficacy
     
  16. Low dose estrogen interrupted hormone replacement therapy
     
  17. Topical testosterone formulations and associated methods
     
  18. Method for the treatment of symptoms related to normal hormonal variations in women
     
  19. Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-.beta.-estradiol to the human organism
     
  20. Method for the treatment of symptoms related to normal hormonal variations in women
     
  21. Methods for treating or reducing prediposition to breast cancer, pre-menstrual syndrome or symptoms associated with menopause by administration of phyto-estrogen
     
  22. Hormone replacement therapy
     
  23. Transdermal application of naturally occurring steroid hormones

Treatment, Huntington's Disease

  1. Antibodies that bind to an epitope on the Huntington's disease protein
     
  2. Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
     
  3. Method and compositions for treating diseases mediated by transglutaminase activity
     
  4. Antibodies specific for proteins having polyglutamine expansions

Treatment, Hurler Syndrome/Mucopolysaccharidosis I

  1. Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase

Treatment, Hyperbilirubinemia

  1. Inhibition of neonatal hyperbilirubinemia in breast fed infants

Treatment, Hyperlipidemia

  1. Target for treating athersclerosis, obesity and type II diabetes
     
  2. Methods and compositions for the treatment of defects in lipoprotein metabolism
     
  3. Charged lipid compositions and methods for their use
     
  4. Intermediate release nicotinic acid compositions for treating hyperlipidemia
     
  5. Mutual prodrug of amlodipine and atorvastatin
     
  6. Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
     
  7. Composition and method for treatment of gastrointestinal disorders and hyperlipidemia

Treatment, Hyperphosphatemia

  1. Preventives and/or remedies for hyperphosphatemia
     
  2. Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same

Treatment, Hypertension Related Disorders

  1. Method for predicting pregnancy-induced hypertension
     
  2. Hypotensors
     
  3. Method for producing a chitosan containing salt having a function of lowering blood pressure
     
  4. Materials and methods for the treatment of hypertension and angina
     
  5. Drug response marker in beta-1 adrenergic receptor gene
     
  6. Scorpion peptide as hypotensive agent
     
  7. Anti-hypertensive dietary supplement
     
  8. Angiopoietins and methods of treating hypertension
     
  9. Felodipine transdermal device and methods
     
  10. Stabilization of quinapril using magnesium oxide
     
  11. Agent for preventing, improving or treating hypertension
     
  12. Process for producing a product containing antihypertensive tripeptides
     
  13. Method for preparing nicotianamine or nicotianamine-containing product
     
  14. Treatment of hypertension using growth hormone in mammals subjected to fetal programming
     
  15. Agents for improving lipid metabolism and reducing high blood pressure
     
  16. Angiotensin converting enzyme homolog and uses therefor
     
  17. Method of assaying modulators of hypertension
     
  18. Transdermal administration of ACE inhibitors
     
  19. Mutual prodrug of amlodipine and atorvastatin
     
  20. Hypertension-treatment and cholesterol-depressant composition comprising extract from mixture of Panax notoginseng and Salvia miltiorrhiza and method of preparing the same
     
  21. Detection of hypertension using immunoreactive metabolic products
     
  22. Methods of treating hypertension
     
  23. Drug screening and diagnosis based on paracrine tubular renin-angiotensin system
     
  24. Monohydrate lisinopril
     
  25. Preventive, alleviative or remedy for hypertension
     
  26. Amorphous compound
     
  27. Satiety inducing composition comprising Neuropeptide Y analogues and methods of inducing satiety and treating a disease or condition associated with it
     
  28. Sodium ion absorption inhibitors, sodium ion excretion accelerators, and preventive and therapeutic agents for diseases resulting from excessive intake of common salt

  29. Pharmaceutical composition comprising at least one aminopeptidase A inhibitor
     
  30. Transdermally administrable medicament with ACE inhibitors
     
  31. Functional sodium chloride compositions
     
  32. Transdermal administration of fenoldopam

Treatment, Hypo/Hyper-glycemia

  1. Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilization of glycemia
     
  2. Disaccharide derivatives for treating hyperglycaemia
     
  3. Blood glucose modulating compositions and methods
     
  4. Method for inhibiting increase of blood sugar level or lowering blood sugar level with a lagerstroemia extract
     
  5. Raising blood sugar level in hypoglycemic mammals by administering inhibitors of dipeptidyl peptidase IV

 

 
     
[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ]
[ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ]
[ Site Map ]